Ibrahim Abubakar
- Universal HIV testing in London tuberculosis clinics: a cluster randomised controlled trialBy Anjana Roy, Sudy Anaraki, Pia Hardelid, Mike Catchpole, Laura C. Rodrigues, Marc Lipman, Samantha Perkins, Anita Roche, Helen R. Stagg, Jose Figueroa and Ibrahim AbubakarAnjana Roy*Health Protection Services, Health Protection AgencySudy Anaraki*Health Protection Services, Health Protection AgencyPia Hardelid*Health Protection Services, Health Protection AgencyMike Catchpole*Health Protection Services, Health Protection AgencyLaura C. Rodrigues#Epidemiology and Population Sciences, London School of Hygiene and Tropical MedicineMarc Lipman¶Division of Medicine, University College LondonSamantha Perkins*Health Protection Services, Health Protection AgencyAnita Roche*Health Protection Services, Health Protection AgencyHelen R. Stagg*Health Protection Services, Health Protection AgencyJose Figueroa+NHS City and Hackney, Dept of Public Health, LondonIbrahim Abubakar*Health Protection Services, Health Protection Agency§Norwich Medical School, University of East Anglia, Norwich, UK
- Do we need bacteriological confirmation of cure in uncomplicated tuberculosis?By Abbey Ursula Leahy, Marc Lipman, Martin Hetzel, Onn Min Kon, Susan Hopkins and Ibrahim AbubakarAbbey Ursula Leahy1University Hospitals Bristol NHS Foundation Trust, BristolMarc Lipman2Royal Free London NHS Foundation Trust and University College London, LondonMartin Hetzel1University Hospitals Bristol NHS Foundation Trust, BristolOnn Min Kon3Imperial College Healthcare NHS Trust and National Heart and Lung Institute, LondonSusan Hopkins2Royal Free London NHS Foundation Trust and University College London, LondonIbrahim Abubakar4Tuberculosis Section, Health Protection Agency Colindale and University College London, London, UK
- Pregnancy: A risk for developing tuberculosis? A national cohort and self-controlled case series study using UK primary care dataBy Dominik Zenner, Michelle Kruijshaar, Nick Andrews and Ibrahim AbubakarDominik ZennerCentre for Infections, Health Protection Agency, London, United KingdomMichelle KruijshaarCentre for Infections, Health Protection Agency, London, United KingdomNick AndrewsCentre for Infections, Health Protection Agency, London, United KingdomIbrahim AbubakarCentre for Infections, Health Protection Agency, London, United Kingdom
- Diagnostic culture confirmation and bacteriological evidence of cure in English adult TB cases: Can we do better?By Abbey Leahy, Martin Hetzel, Onn Kon, Marc Lipman and Ibrahim AbubakarAbbey Leahy1Respiratory Medicine, Bristol Royal Infirmary, University Hospitals Bristol NHS Foundation Trust, Bristol, United KingdomMartin Hetzel1Respiratory Medicine, Bristol Royal Infirmary, University Hospitals Bristol NHS Foundation Trust, Bristol, United KingdomOnn Kon2Respiratory Medicine, St, Mary's Hospital, Imperial College Healthcare NHS Trust, London, United KingdomMarc Lipman3Respiratory Medicine, Royal Free Hospital Hampstead NHS Trust, London, United KingdomIbrahim Abubakar4Infectious Disease Epidemiology, National Centre for Infections, Health Protection Agency, Colindale, London, United Kingdom
- A tale of two settings: the role of the Beijing genotype in the epidemiology of multidrug-resistant tuberculosisBy Helen R. Stagg, Ted Cohen, Mercedes C. Becerra, Laura F. Anderson and Ibrahim AbubakarHelen R. Stagg1Research Dept of Infection and Population Health, University College London22TB Section, Dept of Respiratory Diseases, Public Health England, London, UK33Division of Global Health Equity, Brigham and Women's Hospital, Boston, MATed Cohen33Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA4Dept of Epidemiology, Harvard School of Public Health, Boston, MAMercedes C. Becerra5Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USALaura F. Anderson22TB Section, Dept of Respiratory Diseases, Public Health England, London, UKIbrahim Abubakar1Research Dept of Infection and Population Health, University College London22TB Section, Dept of Respiratory Diseases, Public Health England, London, UK
- Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statementBy Christoph Lange, Ibrahim Abubakar, Jan-Willem C. Alffenaar, Graham Bothamley, Jose A. Caminero, Anna Cristina C. Carvalho, Kwok-Chiu Chang, Luigi Codecasa, Ana Correia, Valeriu Crudu, Peter Davies, Martin Dedicoat, Francis Drobniewski, Raquel Duarte, Cordula Ehlers, Connie Erkens, Delia Goletti, Gunar Günther, Elmira Ibraim, Beate Kampmann, Liga Kuksa, Wiel de Lange, Frank van Leth, Jan van Lunzen, Alberto Matteelli, Dick Menzies, Ignacio Monedero, Elvira Richter, Sabine Rüsch-Gerdes, Andreas Sandgren, Anna Scardigli, Alena Skrahina, Enrico Tortoli, Grigory Volchenkov, Dirk Wagner, Marieke J. van der Werf, Bhanu Williams, Wing-Wai Yew, Jean-Pierre Zellweger and Daniela Maria CirilloChristoph LangeFor the authors’ affiliations see the Acknowledgements sectionIbrahim AbubakarFor the authors’ affiliations see the Acknowledgements sectionJan-Willem C. AlffenaarFor the authors’ affiliations see the Acknowledgements sectionGraham BothamleyFor the authors’ affiliations see the Acknowledgements sectionJose A. CamineroFor the authors’ affiliations see the Acknowledgements sectionAnna Cristina C. CarvalhoFor the authors’ affiliations see the Acknowledgements sectionKwok-Chiu ChangFor the authors’ affiliations see the Acknowledgements sectionLuigi CodecasaFor the authors’ affiliations see the Acknowledgements sectionAna CorreiaFor the authors’ affiliations see the Acknowledgements sectionValeriu CruduFor the authors’ affiliations see the Acknowledgements sectionPeter DaviesFor the authors’ affiliations see the Acknowledgements sectionMartin DedicoatFor the authors’ affiliations see the Acknowledgements sectionFrancis DrobniewskiFor the authors’ affiliations see the Acknowledgements sectionRaquel DuarteFor the authors’ affiliations see the Acknowledgements sectionCordula EhlersFor the authors’ affiliations see the Acknowledgements sectionConnie ErkensFor the authors’ affiliations see the Acknowledgements sectionDelia GolettiFor the authors’ affiliations see the Acknowledgements sectionGunar GüntherFor the authors’ affiliations see the Acknowledgements sectionElmira IbraimFor the authors’ affiliations see the Acknowledgements sectionBeate KampmannFor the authors’ affiliations see the Acknowledgements sectionLiga KuksaFor the authors’ affiliations see the Acknowledgements sectionWiel de LangeFor the authors’ affiliations see the Acknowledgements sectionFrank van LethFor the authors’ affiliations see the Acknowledgements sectionJan van LunzenFor the authors’ affiliations see the Acknowledgements sectionAlberto MatteelliFor the authors’ affiliations see the Acknowledgements sectionDick MenziesFor the authors’ affiliations see the Acknowledgements sectionIgnacio MonederoFor the authors’ affiliations see the Acknowledgements sectionElvira RichterFor the authors’ affiliations see the Acknowledgements sectionSabine Rüsch-GerdesFor the authors’ affiliations see the Acknowledgements sectionAndreas SandgrenFor the authors’ affiliations see the Acknowledgements sectionAnna ScardigliFor the authors’ affiliations see the Acknowledgements sectionAlena SkrahinaFor the authors’ affiliations see the Acknowledgements sectionEnrico TortoliFor the authors’ affiliations see the Acknowledgements sectionGrigory VolchenkovFor the authors’ affiliations see the Acknowledgements sectionDirk WagnerFor the authors’ affiliations see the Acknowledgements sectionMarieke J. van der WerfFor the authors’ affiliations see the Acknowledgements sectionBhanu WilliamsFor the authors’ affiliations see the Acknowledgements sectionWing-Wai YewFor the authors’ affiliations see the Acknowledgements sectionJean-Pierre ZellwegerFor the authors’ affiliations see the Acknowledgements sectionDaniela Maria CirilloFor the authors’ affiliations see the Acknowledgements section
- Population-based outcomes of HIV-TB co- infections in England and WalesBy Dominik Zenner, Stefano Conti, Zheng Yin, Meaghan Kall, Michelle Kruijshaar, Brian Rice, Ibrahim Abubakar and Valerie DelpecheDominik Zenner1National Surveillance - HPS Colindale, Health Protection Agency, London, United KingdomStefano Conti1National Surveillance - HPS Colindale, Health Protection Agency, London, United KingdomZheng Yin1National Surveillance - HPS Colindale, Health Protection Agency, London, United KingdomMeaghan Kall1National Surveillance - HPS Colindale, Health Protection Agency, London, United KingdomMichelle Kruijshaar2Department for Paediatrics, ErasmusMC University Medical Center, Rotterdam, NetherlandsBrian Rice1National Surveillance - HPS Colindale, Health Protection Agency, London, United KingdomIbrahim Abubakar3Centre for Infectious Disease Epidemiology, University College London, London, United KingdomValerie Delpeche1National Surveillance - HPS Colindale, Health Protection Agency, London, United Kingdom
- Active TB case finding strategies in high-risk groups in low-incidence countries - A literature reviewBy Dominik Zenner, Jo Southern, Rob van Hest, Gerard deVries, Helen R. Stagg, Delphine Antoine and Ibrahim AbubakarDominik Zenner1National Tuberculosis Section, Respiratory Diseases Department, Health Protection Agency, London, United KingdomJo Southern1National Tuberculosis Section, Respiratory Diseases Department, Health Protection Agency, London, United KingdomRob van Hest2TB Department, Municipal Public Health Service, Rotterdam-Rijnmond, NetherlandsGerard deVries3KNCV Tuberculosis Foundation, KNCV Tuberculosis Foundation, The Hague, NetherlandsHelen R. Stagg4Research Department of Infection and Population Health, University College London, London, United KingdomDelphine Antoine5Institut De Veille Sanitaire, Institut De Veille Sanitaire, Paris, FranceIbrahim Abubakar4Research Department of Infection and Population Health, University College London, London, United Kingdom
- Universal HIV testing in London TB clinics: cluster randomised controlled trialBy Anjana Roy, Sudy Anaraki, Pia Hardelid, Mike Catchpole, Laura C Rodrigues, Marc Lipman, Samantha Perkins, Anita Roche, Helen R Stagg, Jose Figueroa and Ibrahim AbubakarArticle | Published in 2012 in European Respiratory JournalAnjana RoySudy AnarakiPia HardelidMike CatchpoleLaura C RodriguesMarc LipmanSamantha PerkinsAnita RocheHelen R StaggJose FigueroaIbrahim Abubakar
- A tale of two settings: the role of the Beijing genotype in the epidemiology of MDR-TBBy Helen R. Stagg, Ted Cohen, Mercedes C. Becerra, Laura F. Anderson and Ibrahim AbubakarArticle | Published in 2013 in European Respiratory JournalHelen R. Stagg*Research Dept of Infection and Population Health, University College London#Division of Global Health Equity, Brigham and Women's Hospital¶TB Section, Public Health EnglandTed Cohen#Division of Global Health Equity, Brigham and Women's Hospital+Dept of Epidemiology, Harvard School of Public HealthMercedes C. Becerra§Dept of Global Health and Social Medicine, Harvard Medical SchoolLaura F. Anderson¶TB Section, Public Health EnglandIbrahim Abubakar*Research Dept of Infection and Population Health, University College London¶TB Section, Public Health England
- Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statementBy Christoph Lange, Ibrahim Abubakar, Jan-Willem C. Alffenaar, Graham Bothamley, Jose A. Caminero, Anna Cristina C. Carvalho, Kwok-Chiu Chang, Luigi Codecasa, Ana Correia, Valeriu Crudu, Peter Davies, Martin Dedicoat, Francis Drobniewski, Raquel Duarte, Cordula Ehlers, Connie Erkens, Delia Goletti, Gunar Günther, Elmira Ibraim, Beate Kampmann, Liga Kuksa, Wiel de Lange, Frank van Leth, Jan van Lunzen, Alberto Matteelli, Dick Menzies, Ignacio Monedero, Elvira Richter, Sabine Rüsch-Gerdes, Andreas Sandgren, Anna Scardigli, Alena Skrahina, Enrico Tortoli, Grigory Volchenkov, Dirk Wagner, Marieke J. van der Werf, Bhanu Williams, Wing-Wai Yew, Jean-Pierre Zellweger, Daniela Maria Cirillo and for the TBNETArticle | Published in 2014 in European Respiratory JournalChristoph LangeFor the authors’ affiliations see the Acknowledgements sectionIbrahim AbubakarFor the authors’ affiliations see the Acknowledgements sectionJan-Willem C. AlffenaarFor the authors’ affiliations see the Acknowledgements sectionGraham BothamleyFor the authors’ affiliations see the Acknowledgements sectionJose A. CamineroFor the authors’ affiliations see the Acknowledgements sectionAnna Cristina C. CarvalhoFor the authors’ affiliations see the Acknowledgements sectionKwok-Chiu ChangFor the authors’ affiliations see the Acknowledgements sectionLuigi CodecasaFor the authors’ affiliations see the Acknowledgements sectionAna CorreiaFor the authors’ affiliations see the Acknowledgements sectionValeriu CruduFor the authors’ affiliations see the Acknowledgements sectionPeter DaviesFor the authors’ affiliations see the Acknowledgements sectionMartin DedicoatFor the authors’ affiliations see the Acknowledgements sectionFrancis DrobniewskiFor the authors’ affiliations see the Acknowledgements sectionRaquel DuarteFor the authors’ affiliations see the Acknowledgements sectionCordula EhlersFor the authors’ affiliations see the Acknowledgements sectionConnie ErkensFor the authors’ affiliations see the Acknowledgements sectionDelia GolettiFor the authors’ affiliations see the Acknowledgements sectionGunar GüntherFor the authors’ affiliations see the Acknowledgements sectionElmira IbraimFor the authors’ affiliations see the Acknowledgements sectionBeate KampmannFor the authors’ affiliations see the Acknowledgements sectionLiga KuksaFor the authors’ affiliations see the Acknowledgements sectionWiel de LangeFor the authors’ affiliations see the Acknowledgements sectionFrank van LethFor the authors’ affiliations see the Acknowledgements sectionJan van LunzenFor the authors’ affiliations see the Acknowledgements sectionAlberto MatteelliFor the authors’ affiliations see the Acknowledgements sectionDick MenziesFor the authors’ affiliations see the Acknowledgements sectionIgnacio MonederoFor the authors’ affiliations see the Acknowledgements sectionElvira RichterFor the authors’ affiliations see the Acknowledgements sectionSabine Rüsch-GerdesFor the authors’ affiliations see the Acknowledgements sectionAndreas SandgrenFor the authors’ affiliations see the Acknowledgements sectionAnna ScardigliFor the authors’ affiliations see the Acknowledgements sectionAlena SkrahinaFor the authors’ affiliations see the Acknowledgements sectionEnrico TortoliFor the authors’ affiliations see the Acknowledgements sectionGrigory VolchenkovFor the authors’ affiliations see the Acknowledgements sectionDirk WagnerFor the authors’ affiliations see the Acknowledgements sectionMarieke J. van der WerfFor the authors’ affiliations see the Acknowledgements sectionBhanu WilliamsFor the authors’ affiliations see the Acknowledgements sectionWing-Wai YewFor the authors’ affiliations see the Acknowledgements sectionJean-Pierre ZellwegerFor the authors’ affiliations see the Acknowledgements sectionDaniela Maria CirilloFor the authors’ affiliations see the Acknowledgements sectionFor the authors’ affiliations see the Acknowledgements section
- Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statementBy Christoph Lange, Ibrahim Abubakar, Jan-Willem C. Alffenaar, Graham Bothamley, Jose A. Caminero, Anna Cristina C. Carvalho, Kwok-Chiu Chang, Luigi Codecasa, Ana Correia, Valeriu Crudu, Peter Davies, Martin Dedicoat, Francis Drobniewski, Raquel Duarte, Cordula Ehlers, Connie Erkens, Delia Goletti, Gunar Günther, Elmira Ibraim, Beate Kampmann, Liga Kuksa, Wiel de Lange, Frank van Leth, Jan van Lunzen, Alberto Matteelli, Dick Menzies, Ignacio Monedero, Elvira Richter, Sabine Rüsch-Gerdes, Andreas Sandgren, Anna Scardigli, Alena Skrahina, Enrico Tortoli, Grigory Volchenkov, Dirk Wagner, Marieke J. van der Werf, Bhanu Williams, Wing-Wai Yew, Jean-Pierre Zellweger, Daniela Maria Cirillo and for the TBNETArticle | Published in 2014 in European Respiratory JournalChristoph LangeFor the authors’ affiliations see the Acknowledgements sectionIbrahim AbubakarFor the authors’ affiliations see the Acknowledgements sectionJan-Willem C. AlffenaarFor the authors’ affiliations see the Acknowledgements sectionGraham BothamleyFor the authors’ affiliations see the Acknowledgements sectionJose A. CamineroFor the authors’ affiliations see the Acknowledgements sectionAnna Cristina C. CarvalhoFor the authors’ affiliations see the Acknowledgements sectionKwok-Chiu ChangFor the authors’ affiliations see the Acknowledgements sectionLuigi CodecasaFor the authors’ affiliations see the Acknowledgements sectionAna CorreiaFor the authors’ affiliations see the Acknowledgements sectionValeriu CruduFor the authors’ affiliations see the Acknowledgements sectionPeter DaviesFor the authors’ affiliations see the Acknowledgements sectionMartin DedicoatFor the authors’ affiliations see the Acknowledgements sectionFrancis DrobniewskiFor the authors’ affiliations see the Acknowledgements sectionRaquel DuarteFor the authors’ affiliations see the Acknowledgements sectionCordula EhlersFor the authors’ affiliations see the Acknowledgements sectionConnie ErkensFor the authors’ affiliations see the Acknowledgements sectionDelia GolettiFor the authors’ affiliations see the Acknowledgements sectionGunar GüntherFor the authors’ affiliations see the Acknowledgements sectionElmira IbraimFor the authors’ affiliations see the Acknowledgements sectionBeate KampmannFor the authors’ affiliations see the Acknowledgements sectionLiga KuksaFor the authors’ affiliations see the Acknowledgements sectionWiel de LangeFor the authors’ affiliations see the Acknowledgements sectionFrank van LethFor the authors’ affiliations see the Acknowledgements sectionJan van LunzenFor the authors’ affiliations see the Acknowledgements sectionAlberto MatteelliFor the authors’ affiliations see the Acknowledgements sectionDick MenziesFor the authors’ affiliations see the Acknowledgements sectionIgnacio MonederoFor the authors’ affiliations see the Acknowledgements sectionElvira RichterFor the authors’ affiliations see the Acknowledgements sectionSabine Rüsch-GerdesFor the authors’ affiliations see the Acknowledgements sectionAndreas SandgrenFor the authors’ affiliations see the Acknowledgements sectionAnna ScardigliFor the authors’ affiliations see the Acknowledgements sectionAlena SkrahinaFor the authors’ affiliations see the Acknowledgements sectionEnrico TortoliFor the authors’ affiliations see the Acknowledgements sectionGrigory VolchenkovFor the authors’ affiliations see the Acknowledgements sectionDirk WagnerFor the authors’ affiliations see the Acknowledgements sectionMarieke J. van der WerfFor the authors’ affiliations see the Acknowledgements sectionBhanu WilliamsFor the authors’ affiliations see the Acknowledgements sectionWing-Wai YewFor the authors’ affiliations see the Acknowledgements sectionJean-Pierre ZellwegerFor the authors’ affiliations see the Acknowledgements sectionDaniela Maria CirilloFor the authors’ affiliations see the Acknowledgements sectionFor the authors’ affiliations see the Acknowledgements section
- The protective effect of BCG vaccination against mycobacterium tuberculosis infection in children: A systematic reviewBy Anjana Roy, Michael Eisenhut, Ross Harris, Laura Rodrigues, Saranya Sridhar, Stephanie Habermann, Luke Snell, Punam Mangtani, Ifedayo Adetifa, Ajit Lalvani and Ibrahim AbubakarAnjana Roy1Centre for Infectious Disease Surveillance and Control, Public Health England, London, United KingdomMichael Eisenhut2Paediatrics, Luton and Dunstable University Hospital NHS Foundation Trust, Luton, United KingdomRoss Harris1Centre for Infectious Disease Surveillance and Control, Public Health England, London, United KingdomLaura Rodrigues3Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United KingdomSaranya Sridhar4Tuberculosis Research Unit, National Heart and Lung Institute, Imperial College London, London, United KingdomStephanie Habermann2Paediatrics, Luton and Dunstable University Hospital NHS Foundation Trust, Luton, United KingdomLuke Snell2Paediatrics, Luton and Dunstable University Hospital NHS Foundation Trust, Luton, United KingdomPunam Mangtani3Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United KingdomIfedayo Adetifa5Medical Research Council, Fajara, GambiaAjit Lalvani4Tuberculosis Research Unit, National Heart and Lung Institute, Imperial College London, London, United KingdomIbrahim Abubakar1Centre for Infectious Disease Surveillance and Control, Public Health England, London, United Kingdom
- Towards tuberculosis elimination: an action framework for low-incidence countriesBy Knut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, Lia D'Ambrosio, Gerard de Vries, Roland Diel, Paul Douglas, Dennis Falzon, Marc-Andre Gaudreau, Delia Goletti, Edilberto R. González Ochoa, Philip LoBue, Alberto Matteelli, Howard Njoo, Ivan Solovic, Alistair Story, Tamara Tayeb, Marieke J. van der Werf, Diana Weil, Jean-Pierre Zellweger, Mohamed Abdel Aziz, Mohamed R.M. Al Lawati, Stefano Aliberti, Wouter Arrazola de Oñate, Draurio Barreira, Vineet Bhatia, Francesco Blasi, Amy Bloom, Judith Bruchfeld, Francesco Castelli, Rosella Centis, Daniel Chemtob, Daniela M. Cirillo, Alberto Colorado, Andrei Dadu, Ulf R. Dahle, Laura De Paoli, Hannah M. Dias, Raquel Duarte, Lanfranco Fattorini, Mina Gaga, Haileyesus Getahun, Philippe Glaziou, Lasha Goguadze, Mirtha del Granado, Walter Haas, Asko Järvinen, Geun-Yong Kwon, Davide Mosca, Payam Nahid, Nobuyuki Nishikiori, Isabel Noguer, Joan O'Donnell, Analita Pace-Asciak, Maria G. Pompa, Gilda G. Popescu, Carlos Robalo Cordeiro, Karin Rønning, Morten Ruhwald, Jean-Paul Sculier, Aleksandar Simunović, Alison Smith-Palmer, Giovanni Sotgiu, Giorgia Sulis, Carlos A. Torres-Duque, Kazunori Umeki, Mukund Uplekar, Catharina van Weezenbeek, Tuula Vasankari, Robert J. Vitillo, Constantia Voniatis, Maryse Wanlin and Mario C. RaviglioneKnut Lönnroth1Global TB Programme, World Health Organization, Geneva, Switzerland60Both authors contributed equallyGiovanni Battista Migliori2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, Italy60Both authors contributed equallyIbrahim Abubakar3TB Section, University College London and Public Health England, London, UKLia D'Ambrosio2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, ItalyGerard de Vries4KNCV Tuberculosis Foundation, The Hague, The NetherlandsRoland Diel5University Hospital Schleswig Holstein, Institute for Epidemiology, Kiel, GermanyPaul Douglas6Global Health Borders Refugee and Onshore Services, Dept of Immigration and Border Protection, Sydney, AustraliaDennis Falzon1Global TB Programme, World Health Organization, Geneva, SwitzerlandMarc-Andre Gaudreau7Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, CanadaDelia Goletti8National Institute for Infectious Diseases, Rome, ItalyEdilberto R. González Ochoa9Research and Surveillance Group on TB, Leprosy and ARI, Epidemiology Board, Institute of Tropical Medicine “Pedro Kourí”, Havana, CubaPhilip LoBue10Division of TB Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USAAlberto Matteelli1Global TB Programme, World Health Organization, Geneva, SwitzerlandHoward Njoo7Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, CanadaIvan Solovic11TB Dept, National Institute for TB, Respiratory Diseases and Thoracic Surgery, Vysne Hagy, Catholic University, Ružomberok, SlovakiaAlistair Story12Find and Treat, London, UKTamara Tayeb13National TB Control Programme, Ministry of Health, Riyadh, Saudi ArabiaMarieke J. van der Werf14European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenDiana Weil1Global TB Programme, World Health Organization, Geneva, SwitzerlandJean-Pierre Zellweger15Swiss Lung Association, Bern, SwitzerlandMohamed Abdel Aziz16WHO Regional Office for the Eastern Mediterranean, Cairo, EgyptMohamed R.M. Al Lawati17Ministry of Health, Muscat, OmanStefano Aliberti18Università degli Studi di Milano – Bicocca, UO Clinica Pneumologica, AO San Gerardo, Monza, ItalyWouter Arrazola de Oñate19Belgian Lung and Tuberculosis Association, Brussels, BelgiumDraurio Barreira20Ministry of Health, Brasilia, BrazilVineet Bhatia1Global TB Programme, World Health Organization, Geneva, SwitzerlandFrancesco Blasi21Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyAmy Bloom22US Agency for International Development, Washington, DC, USAJudith Bruchfeld23Unit of Infectious Diseases, Institution of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, SwedenFrancesco Castelli24University of Brescia, Brescia, ItalyRosella Centis2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, ItalyDaniel Chemtob25Ministry of Health, Jerusalem, IsraelDaniela M. Cirillo26IRCCS San Raffaele Scientific Institute, Milan, ItalyAlberto Colorado27Advocates for Health International, San Diego, CA, USAAndrei Dadu28TB and M/XDR-TB Control Programme, WHO Regional Office for Europe, Copenhagen, DenmarkUlf R. Dahle29Norwegian Institute of Public Health, Oslo, NorwayLaura De Paoli30Médecins sans Frontières, Rome, ItalyHannah M. Dias1Global TB Programme, World Health Organization, Geneva, SwitzerlandRaquel Duarte31General Directorate of Health, Lisbon, PortugalLanfranco Fattorini32Istituto Superiore di Sanita, Rome, ItalyMina Gaga33National Referral Centre for Mycobacteria, Athens Chest Hospital, Ministry of Health, Athens, GreeceHaileyesus Getahun1Global TB Programme, World Health Organization, Geneva, SwitzerlandPhilippe Glaziou1Global TB Programme, World Health Organization, Geneva, SwitzerlandLasha Goguadze34International Federation of Red Cross and Red Crescent Societies, Geneva, SwitzerlandMirtha del Granado35WHO Regional Office for the Americas, Washington, DC, USAWalter Haas36Dept of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, GermanyAsko Järvinen37Finnish Lung Health Association, Helsinki, Finland38Helsinki University Central Hospital, Division of Infectious Diseases, Helsinki, FinlandGeun-Yong Kwon39Korea Centers for Disease Control and Prevention (KCDC), Ministry of Health and Welfare, Seoul, Republic of KoreaDavide Mosca40International Organization for Migration, Geneva, SwitzerlandPayam Nahid41University of California, San Francisco, CA, USA42American Thoracic Society (ATS), New York, NY, USANobuyuki Nishikiori43Stop TB and Leprosy Elimination, WHO Regional Office for the Western Pacific, Manila, PhilippinesIsabel Noguer44Instituto de Salud Carlos III, Madrid, SpainJoan O'Donnell45HSE Health Protection Surveillance Centre, Dublin, IrelandAnalita Pace-Asciak46Ministry for Health, Valletta, MaltaMaria G. Pompa47Ministry of Health, Rome, ItalyGilda G. Popescu48Pneumology Institute Marius Nasta, Bucharest, RomaniaCarlos Robalo Cordeiro49Coimbra University Hospital, Coimbra, PortugalKarin Rønning29Norwegian Institute of Public Health, Oslo, NorwayMorten Ruhwald50Statens Serum Institut (SSI), Copenhagen, DenmarkJean-Paul Sculier51Institut Jules Bordet (ULB), Brussels, BelgiumAleksandar Simunović52Croatian National Institute of Public Health, Zagreb, CroatiaAlison Smith-Palmer53Health Protection Scotland, Glasgow, UKGiovanni Sotgiu54Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyGiorgia Sulis1Global TB Programme, World Health Organization, Geneva, SwitzerlandCarlos A. Torres-Duque55Asociacion Latinoamericana de Torax (ALAT) - Fundacion Neumologica Colombiana, Bogota, ColombiaKazunori Umeki56Ministry of Health, Labour and Welfare, Tokyo, JapanMukund Uplekar1Global TB Programme, World Health Organization, Geneva, SwitzerlandCatharina van Weezenbeek4KNCV Tuberculosis Foundation, The Hague, The NetherlandsTuula Vasankari37Finnish Lung Health Association, Helsinki, FinlandRobert J. Vitillo57Caritas Internationalis, Geneva, SwitzerlandConstantia Voniatis58Ministry of Health, Nicosia, CyprusMaryse Wanlin59Fonds des Affections Respiratoires (FARES), Brussels, BelgiumMario C. Raviglione1Global TB Programme, World Health Organization, Geneva, Switzerland
- Towards tuberculosis elimination: an action framework for low-incidence countriesBy Knut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, Lia D'Ambrosio, Gerard de Vries, Roland Diel, Paul Douglas, Dennis Falzon, Marc-Andre Gaudreau, Delia Goletti, Edilberto R. González Ochoa, Philip LoBue, Alberto Matteelli, Howard Njoo, Ivan Solovic, Alistair Story, Tamara Tayeb, Marieke J. van der Werf, Diana Weil, Jean-Pierre Zellweger, Mohamed Abdel Aziz, Mohamed R.M. Al Lawati, Stefano Aliberti, Wouter Arrazola de Oñate, Draurio Barreira, Vineet Bhatia, Francesco Blasi, Amy Bloom, Judith Bruchfeld, Francesco Castelli, Rosella Centis, Daniel Chemtob, Daniela M. Cirillo, Alberto Colorado, Andrei Dadu, Ulf R. Dahle, Laura De Paoli, Hannah M. Dias, Raquel Duarte, Lanfranco Fattorini, Mina Gaga, Haileyesus Getahun, Philippe Glaziou, Lasha Goguadze, Mirtha del Granado, Walter Haas, Asko Järvinen, Geun-Yong Kwon, Davide Mosca, Payam Nahid, Nobuyuki Nishikiori, Isabel Noguer, Joan O'Donnell, Analita Pace-Asciak, Maria G. Pompa, Gilda G. Popescu, Carlos Robalo Cordeiro, Karin Rønning, Morten Ruhwald, Jean-Paul Sculier, Aleksandar Simunović, Alison Smith-Palmer, Giovanni Sotgiu, Giorgia Sulis, Carlos A. Torres-Duque, Kazunori Umeki, Mukund Uplekar, Catharina van Weezenbeek, Tuula Vasankari, Robert J. Vitillo, Constantia Voniatis, Maryse Wanlin and Mario C. RaviglioneArticle | Published in 2015 in European Respiratory JournalKnut Lönnroth1Global TB Programme, World Health Organization, Geneva, Switzerland60Both authors contributed equallyGiovanni Battista Migliori2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, Italy60Both authors contributed equallyIbrahim Abubakar3TB Section, University College London and Public Health England, London, UKLia D'Ambrosio2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, ItalyGerard de Vries4KNCV Tuberculosis Foundation, The Hague, The NetherlandsRoland Diel5University Hospital Schleswig Holstein, Institute for Epidemiology, Kiel, GermanyPaul Douglas6Global Health Borders Refugee and Onshore Services, Dept of Immigration and Border Protection, Sydney, AustraliaDennis Falzon1Global TB Programme, World Health Organization, Geneva, SwitzerlandMarc-Andre Gaudreau7Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, CanadaDelia Goletti8National Institute for Infectious Diseases, Rome, ItalyEdilberto R. González Ochoa9Research and Surveillance Group on TB, Leprosy and ARI, Epidemiology Board, Institute of Tropical Medicine “Pedro Kourí”, Havana, CubaPhilip LoBue10Division of TB Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USAAlberto Matteelli1Global TB Programme, World Health Organization, Geneva, SwitzerlandHoward Njoo7Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, CanadaIvan Solovic11TB Dept, National Institute for TB, Respiratory Diseases and Thoracic Surgery, Vysne Hagy, Catholic University, Ružomberok, SlovakiaAlistair Story12Find and Treat, London, UKTamara Tayeb13National TB Control Programme, Ministry of Health, Riyadh, Saudi ArabiaMarieke J. van der Werf14European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenDiana Weil1Global TB Programme, World Health Organization, Geneva, SwitzerlandJean-Pierre Zellweger15Swiss Lung Association, Bern, SwitzerlandMohamed Abdel Aziz16WHO Regional Office for the Eastern Mediterranean, Cairo, EgyptMohamed R.M. Al Lawati17Ministry of Health, Muscat, OmanStefano Aliberti18Università degli Studi di Milano – Bicocca, UO Clinica Pneumologica, AO San Gerardo, Monza, ItalyWouter Arrazola de Oñate19Belgian Lung and Tuberculosis Association, Brussels, BelgiumDraurio Barreira20Ministry of Health, Brasilia, BrazilVineet Bhatia1Global TB Programme, World Health Organization, Geneva, SwitzerlandFrancesco Blasi21Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyAmy Bloom22US Agency for International Development, Washington, DC, USAJudith Bruchfeld23Unit of Infectious Diseases, Institution of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, SwedenFrancesco Castelli24University of Brescia, Brescia, ItalyRosella Centis2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, ItalyDaniel Chemtob25Ministry of Health, Jerusalem, IsraelDaniela M. Cirillo26IRCCS San Raffaele Scientific Institute, Milan, ItalyAlberto Colorado27Advocates for Health International, San Diego, CA, USAAndrei Dadu28TB and M/XDR-TB Control Programme, WHO Regional Office for Europe, Copenhagen, DenmarkUlf R. Dahle29Norwegian Institute of Public Health, Oslo, NorwayLaura De Paoli30Médecins sans Frontières, Rome, ItalyHannah M. Dias1Global TB Programme, World Health Organization, Geneva, SwitzerlandRaquel Duarte31General Directorate of Health, Lisbon, PortugalLanfranco Fattorini32Istituto Superiore di Sanita, Rome, ItalyMina Gaga33National Referral Centre for Mycobacteria, Athens Chest Hospital, Ministry of Health, Athens, GreeceHaileyesus Getahun1Global TB Programme, World Health Organization, Geneva, SwitzerlandPhilippe Glaziou1Global TB Programme, World Health Organization, Geneva, SwitzerlandLasha Goguadze34International Federation of Red Cross and Red Crescent Societies, Geneva, SwitzerlandMirtha del Granado35WHO Regional Office for the Americas, Washington, DC, USAWalter Haas36Dept of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, GermanyAsko Järvinen37Finnish Lung Health Association, Helsinki, Finland38Helsinki University Central Hospital, Division of Infectious Diseases, Helsinki, FinlandGeun-Yong Kwon39Korea Centers for Disease Control and Prevention (KCDC), Ministry of Health and Welfare, Seoul, Republic of KoreaDavide Mosca40International Organization for Migration, Geneva, SwitzerlandPayam Nahid41University of California, San Francisco, CA, USA42American Thoracic Society (ATS), New York, NY, USANobuyuki Nishikiori43Stop TB and Leprosy Elimination, WHO Regional Office for the Western Pacific, Manila, PhilippinesIsabel Noguer44Instituto de Salud Carlos III, Madrid, SpainJoan O'Donnell45HSE Health Protection Surveillance Centre, Dublin, IrelandAnalita Pace-Asciak46Ministry for Health, Valletta, MaltaMaria G. Pompa47Ministry of Health, Rome, ItalyGilda G. Popescu48Pneumology Institute Marius Nasta, Bucharest, RomaniaCarlos Robalo Cordeiro49Coimbra University Hospital, Coimbra, PortugalKarin Rønning29Norwegian Institute of Public Health, Oslo, NorwayMorten Ruhwald50Statens Serum Institut (SSI), Copenhagen, DenmarkJean-Paul Sculier51Institut Jules Bordet (ULB), Brussels, BelgiumAleksandar Simunović52Croatian National Institute of Public Health, Zagreb, CroatiaAlison Smith-Palmer53Health Protection Scotland, Glasgow, UKGiovanni Sotgiu54Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyGiorgia Sulis1Global TB Programme, World Health Organization, Geneva, SwitzerlandCarlos A. Torres-Duque55Asociacion Latinoamericana de Torax (ALAT) - Fundacion Neumologica Colombiana, Bogota, ColombiaKazunori Umeki56Ministry of Health, Labour and Welfare, Tokyo, JapanMukund Uplekar1Global TB Programme, World Health Organization, Geneva, SwitzerlandCatharina van Weezenbeek4KNCV Tuberculosis Foundation, The Hague, The NetherlandsTuula Vasankari37Finnish Lung Health Association, Helsinki, FinlandRobert J. Vitillo57Caritas Internationalis, Geneva, SwitzerlandConstantia Voniatis58Ministry of Health, Nicosia, CyprusMaryse Wanlin59Fonds des Affections Respiratoires (FARES), Brussels, BelgiumMario C. Raviglione1Global TB Programme, World Health Organization, Geneva, Switzerland
- Decreasing cost effectiveness of testing for latent TB in HIV in a low TB incidence areaBy Santino Capocci, Colette Smith, Stephen Morris, Sanjay Bhagani, Ian Cropley, Ibrahim Abubakar, Margaret Johnson and Marc LipmanArticle | Published in 2015 in European Respiratory JournalSantino Capocci1Department of HIV and Thoracic Medicine, Royal Free London NHS Foundation Trust, London, UKColette Smith2Department of Infection and Population Health, University College London, London, UKStephen Morris3Department of Applied Health Research, University College London, London, UKSanjay Bhagani4Department of Infectious Diseases, Royal Free London NHS Foundation Trust, London, UKIan Cropley4Department of Infectious Diseases, Royal Free London NHS Foundation Trust, London, UKIbrahim Abubakar5Research Department of Infection and Population Health, University College London, London, UK6Medical Research Council Clinical Trials Unit, London, UKMargaret Johnson1Department of HIV and Thoracic Medicine, Royal Free London NHS Foundation Trust, London, UKMarc Lipman1Department of HIV and Thoracic Medicine, Royal Free London NHS Foundation Trust, London, UK7Division of Medicine, University College London, London, UK
- Risk factors for the misdiagnosis of tuberculosis in the UK, 2001–2011By Debora Pedrazzoli, Ibrahim Abubakar, Helena Potts, Paul R. Hunter, Michelle E. Kruijshaar, Onn Min Kon and Jo SouthernArticle | Published in 2015 in European Respiratory JournalDebora Pedrazzoli1TB Modelling Group, TB Centre and CMMID, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK2TB Section, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UKIbrahim Abubakar2TB Section, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK3Centre for Infectious Disease Epidemiology, Research Department of Infection and Population Health, University College London, London, UKHelena Potts4Norwich Medical School, University of East Anglia, Norwich, UKPaul R. Hunter4Norwich Medical School, University of East Anglia, Norwich, UKMichelle E. Kruijshaar5Centre for Lysosomal and Metabolic Diseases, Sophia Children's Hospital, Erasmus MC University Medical Centre, Rotterdam, The NetherlandsOnn Min Kon6Chest and Allergy Clinic, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UKJo Southern1TB Modelling Group, TB Centre and CMMID, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
- Decreasing cost effectiveness of testing for latent TB in HIV in a low TB incidence areaBy Santino Capocci, Colette Smith, Stephen Morris, Sanjay Bhagani, Ian Cropley, Ibrahim Abubakar, Margaret Johnson and Marc LipmanSantino Capocci1Department of HIV and Thoracic Medicine, Royal Free London NHS Foundation Trust, London, UKColette Smith2Department of Infection and Population Health, University College London, London, UKStephen Morris3Department of Applied Health Research, University College London, London, UKSanjay Bhagani4Department of Infectious Diseases, Royal Free London NHS Foundation Trust, London, UKIan Cropley4Department of Infectious Diseases, Royal Free London NHS Foundation Trust, London, UKIbrahim Abubakar5Research Department of Infection and Population Health, University College London, London, UK6Medical Research Council Clinical Trials Unit, London, UKMargaret Johnson1Department of HIV and Thoracic Medicine, Royal Free London NHS Foundation Trust, London, UKMarc Lipman1Department of HIV and Thoracic Medicine, Royal Free London NHS Foundation Trust, London, UK7Division of Medicine, University College London, London, UK
- Risk factors for the misdiagnosis of tuberculosis in the UK, 2001–2011By Debora Pedrazzoli, Ibrahim Abubakar, Helena Potts, Paul R. Hunter, Michelle E. Kruijshaar, Onn Min Kon and Jo SouthernDebora Pedrazzoli1TB Modelling Group, TB Centre and CMMID, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK2TB Section, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UKIbrahim Abubakar2TB Section, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK3Centre for Infectious Disease Epidemiology, Research Department of Infection and Population Health, University College London, London, UKHelena Potts4Norwich Medical School, University of East Anglia, Norwich, UKPaul R. Hunter4Norwich Medical School, University of East Anglia, Norwich, UKMichelle E. Kruijshaar5Centre for Lysosomal and Metabolic Diseases, Sophia Children's Hospital, Erasmus MC University Medical Centre, Rotterdam, The NetherlandsOnn Min Kon6Chest and Allergy Clinic, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UKJo Southern1TB Modelling Group, TB Centre and CMMID, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
- Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countriesBy Haileyesus Getahun, Alberto Matteelli, Ibrahim Abubakar, Mohamed Abdel Aziz, Annabel Baddeley, Draurio Barreira, Saskia Den Boon, Susana Marta Borroto Gutierrez, Judith Bruchfeld, Erlina Burhan, Solange Cavalcante, Rolando Cedillos, Richard Chaisson, Cynthia Bin-Eng Chee, Lucy Chesire, Elizabeth Corbett, Masoud Dara, Justin Denholm, Gerard de Vries, Dennis Falzon, Nathan Ford, Margaret Gale-Rowe, Chris Gilpin, Enrico Girardi, Un-Yeong Go, Darshini Govindasamy, Alison D. Grant, Malgorzata Grzemska, Ross Harris, C. Robert Horsburgh, Asker Ismayilov, Ernesto Jaramillo, Sandra Kik, Katharina Kranzer, Christian Lienhardt, Philip LoBue, Knut Lönnroth, Guy Marks, Dick Menzies, Giovanni Battista Migliori, Davide Mosca, Ya Diul Mukadi, Alwyn Mwinga, Lisa Nelson, Nobuyuki Nishikiori, Anouk Oordt-Speets, Molebogeng Xheedha Rangaka, Andreas Reis, Lisa Rotz, Andreas Sandgren, Monica Sañé Schepisi, Holger J. Schünemann, Surender Kumar Sharma, Giovanni Sotgiu, Helen R. Stagg, Timothy R. Sterling, Tamara Tayeb, Mukund Uplekar, Marieke J. van der Werf, Wim Vandevelde, Femke van Kessel, Anna van't Hoog, Jay K. Varma, Natalia Vezhnina, Constantia Voniatis, Marije Vonk Noordegraaf-Schouten, Diana Weil, Karin Weyer, Robert John Wilkinson, Takashi Yoshiyama, Jean Pierre Zellweger and Mario RaviglioneArticle | Published in 2015 in European Respiratory JournalHaileyesus Getahun1The Global TB Programme, World Health Organization, Geneva, SwitzerlandAlberto Matteelli1The Global TB Programme, World Health Organization, Geneva, SwitzerlandIbrahim Abubakar2Dept of Infection and Population Health, University College London, London, UK3Public Health England, London, UKMohamed Abdel Aziz4World Health Organization, Regional Office for Eastern Mediterranean, EgyptAnnabel Baddeley1The Global TB Programme, World Health Organization, Geneva, SwitzerlandDraurio Barreira5National TB Programme, Ministry of Health, Brasilia, BrazilSaskia Den Boon6Independent consultant, SwitzerlandSusana Marta Borroto Gutierrez7Pedro Kourí Institute of Tropical Medicine, La Habana, CubaJudith Bruchfeld8Unit of Infectious Diseases, Dept of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, SwedenErlina Burhan9Dept of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Indonesia and Persahabatan Hospital, Jakarta, IndonesiaSolange Cavalcante10Evandro Chagas National Institute of Infectious Diseases, FIOCRUZ, Rio de Janeiro, BrazilRolando Cedillos11Hospital Nacionale Rosales, San Salvador, El SalvadorRichard Chaisson12Center for TB Research, John Hopkins University, Baltimore, MD, USACynthia Bin-Eng Chee13Tan Tock Seng Hospital, SingaporeLucy Chesire14TB Advocacy Consortium, Nairobi, KenyaElizabeth Corbett15London School of Hygiene and Tropical Medicine, Blantyre, MalawiMasoud Dara16World Health Organization, Regional Office for Europe, DenmarkJustin Denholm17Victorian Tuberculosis Program, Melbourne, AustraliaGerard de Vries18KNCV Tuberculosis Foundation, Den Haag, The NetherlandsDennis Falzon1The Global TB Programme, World Health Organization, Geneva, SwitzerlandNathan Ford19Dept of HIV and Global Hepatitis Programme, World Health Organization, SwitzerlandMargaret Gale-Rowe20Public Health Agency of Canada, Ottawa, ON, CanadaChris Gilpin1The Global TB Programme, World Health Organization, Geneva, SwitzerlandEnrico Girardi21Istituto Nazionale Malattie Infettive L. Spallanzani, Rome, ItalyUn-Yeong Go22Dept of HIV/AIDS and TB Control Korea, Korea Centers for Disease Control and Prevention, Republic of KoreaDarshini Govindasamy23Health Systems Research Unit, South African Medical Research Council, South AfricaAlison D. Grant24Dept of Clinical Research, London School of Hygiene and Tropical Medicine, London, UKMalgorzata Grzemska1The Global TB Programme, World Health Organization, Geneva, SwitzerlandRoss Harris3Public Health England, London, UKC. Robert Horsburgh Jr.25Dept of Epidemiology, Boston University School of Public Health, Boston, MA, USAAsker Ismayilov26Main Medical Department, Ministry of Justice, AzerbaijanErnesto Jaramillo1The Global TB Programme, World Health Organization, Geneva, SwitzerlandSandra Kik27McGill International TB Centre, and Dept of Epidemiology and Biostatistics, McGill University, Montreal, QC, CanadaKatharina Kranzer24Dept of Clinical Research, London School of Hygiene and Tropical Medicine, London, UKChristian Lienhardt1The Global TB Programme, World Health Organization, Geneva, SwitzerlandPhilip LoBue28Centers for Disease Control and Prevention, USAKnut Lönnroth1The Global TB Programme, World Health Organization, Geneva, Switzerland29Dept of Public Health Sciences, Karolinska Institute, Solna, SwedenGuy Marks30Woolcock Institute of Medical Research University of Sydney and UNSW Australia, Sydney, AustraliaDick Menzies27McGill International TB Centre, and Dept of Epidemiology and Biostatistics, McGill University, Montreal, QC, CanadaGiovanni Battista Migliori31WHO Collaborating Center for TB and Lung Diseases Fondazione S. Maugeri, Tradate, ItalyDavide Mosca32Migration Health Department, International Organization of Migration, Geneva, SwitzerlandYa Diul Mukadi33Infectious Disease Division, Bureau for Global Health, US Agency for International Development, Washington, DC, USAAlwyn Mwinga34Zambart Project, Lusaka, ZambiaLisa Nelson19Dept of HIV and Global Hepatitis Programme, World Health Organization, SwitzerlandNobuyuki Nishikiori35World Health Organization, Regional Office for the Western Pacific, PhilippinesAnouk Oordt-Speets36Pallas Health Research and Consultancy BV, Rotterdam, The NetherlandsMolebogeng Xheedha Rangaka2Dept of Infection and Population Health, University College London, London, UK37Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South AfricaAndreas Reis38Knowledge, Ethics and Research Department, World Health Organization, SwitzerlandLisa Rotz28Centers for Disease Control and Prevention, USAAndreas Sandgren39European Centre for Disease Prevention and Control, Stockholm, SwedenMonica Sañé Schepisi21Istituto Nazionale Malattie Infettive L. Spallanzani, Rome, ItalyHolger J. Schünemann40Dept of Clinical Epidemiology and Biostatistics and Dept of Medicine, GRADE Center, McMaster University, Hamilton, ON, CanadaSurender Kumar Sharma38Knowledge, Ethics and Research Department, World Health Organization, SwitzerlandGiovanni Sotgiu39European Centre for Disease Prevention and Control, Stockholm, SwedenHelen R. Stagg2Dept of Infection and Population Health, University College London, London, UKTimothy R. Sterling43Vanderbilt University School of Medicine, Nashville, TN, USATamara Tayeb44National TB Programme, Ministry of Health, Riyadh, Saudi ArabiaMukund Uplekar1The Global TB Programme, World Health Organization, Geneva, SwitzerlandMarieke J. van der Werf39European Centre for Disease Prevention and Control, Stockholm, SwedenWim Vandevelde45European AIDS Treatment Group, Brussels, BelgiumFemke van Kessel36Pallas Health Research and Consultancy BV, Rotterdam, The NetherlandsAnna van't Hoog46Academic Medical Centre, University of Amsterdam, Dept of Global Health, Amsterdam, The NetherlandsJay K. Varma28Centers for Disease Control and Prevention, USANatalia Vezhnina47HIV/TB and Penal System Projects, Russian FederationConstantia Voniatis48Clinical Laboratories, Ministry of Health, Nicosia, CyprusMarije Vonk Noordegraaf-Schouten36Pallas Health Research and Consultancy BV, Rotterdam, The NetherlandsDiana Weil1The Global TB Programme, World Health Organization, Geneva, SwitzerlandKarin Weyer1The Global TB Programme, World Health Organization, Geneva, SwitzerlandRobert John Wilkinson37Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa49Francis Crick Institute Mill Hill Laboratory, Dept of Medicine, Imperial College London, London, UKTakashi Yoshiyama50Fukujuji Hospital, Japan Anti Tuberculosis Association, Tokyo, JapanJean Pierre Zellweger51Tuberculosis Competence Centre, Berne, SwitzerlandMario Raviglione1The Global TB Programme, World Health Organization, Geneva, Switzerland
- Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countriesBy Haileyesus Getahun, Alberto Matteelli, Ibrahim Abubakar, Mohamed Abdel Aziz, Annabel Baddeley, Draurio Barreira, Saskia Den Boon, Susana Marta Borroto Gutierrez, Judith Bruchfeld, Erlina Burhan, Solange Cavalcante, Rolando Cedillos, Richard Chaisson, Cynthia Bin-Eng Chee, Lucy Chesire, Elizabeth Corbett, Masoud Dara, Justin Denholm, Gerard de Vries, Dennis Falzon, Nathan Ford, Margaret Gale-Rowe, Chris Gilpin, Enrico Girardi, Un-Yeong Go, Darshini Govindasamy, Alison D. Grant, Malgorzata Grzemska, Ross Harris, C. Robert Horsburgh Jr, Asker Ismayilov, Ernesto Jaramillo, Sandra Kik, Katharina Kranzer, Christian Lienhardt, Philip LoBue, Knut Lönnroth, Guy Marks, Dick Menzies, Giovanni Battista Migliori, Davide Mosca, Ya Diul Mukadi, Alwyn Mwinga, Lisa Nelson, Nobuyuki Nishikiori, Anouk Oordt-Speets, Molebogeng Xheedha Rangaka, Andreas Reis, Lisa Rotz, Andreas Sandgren, Monica Sañé Schepisi, Holger J. Schünemann, Surender Kumar Sharma, Giovanni Sotgiu, Helen R. Stagg, Timothy R. Sterling, Tamara Tayeb, Mukund Uplekar, Marieke J. van der Werf, Wim Vandevelde, Femke van Kessel, Anna van't Hoog, Jay K. Varma, Natalia Vezhnina, Constantia Voniatis, Marije Vonk Noordegraaf-Schouten, Diana Weil, Karin Weyer, Robert John Wilkinson, Takashi Yoshiyama, Jean Pierre Zellweger and Mario RaviglioneHaileyesus Getahun1The Global TB Programme, World Health Organization, Geneva, SwitzerlandAlberto Matteelli1The Global TB Programme, World Health Organization, Geneva, SwitzerlandIbrahim Abubakar2Dept of Infection and Population Health, University College London, London, UK3Public Health England, London, UKMohamed Abdel Aziz4World Health Organization, Regional Office for Eastern Mediterranean, EgyptAnnabel Baddeley1The Global TB Programme, World Health Organization, Geneva, SwitzerlandDraurio Barreira5National TB Programme, Ministry of Health, Brasilia, BrazilSaskia Den Boon6Independent consultant, SwitzerlandSusana Marta Borroto Gutierrez7Pedro Kourí Institute of Tropical Medicine, La Habana, CubaJudith Bruchfeld8Unit of Infectious Diseases, Dept of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, SwedenErlina Burhan9Dept of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Indonesia and Persahabatan Hospital, Jakarta, IndonesiaSolange Cavalcante10Evandro Chagas National Institute of Infectious Diseases, FIOCRUZ, Rio de Janeiro, BrazilRolando Cedillos11Hospital Nacionale Rosales, San Salvador, El SalvadorRichard Chaisson12Center for TB Research, John Hopkins University, Baltimore, MD, USACynthia Bin-Eng Chee13Tan Tock Seng Hospital, SingaporeLucy Chesire14TB Advocacy Consortium, Nairobi, KenyaElizabeth Corbett15London School of Hygiene and Tropical Medicine, Blantyre, MalawiMasoud Dara16World Health Organization, Regional Office for Europe, DenmarkJustin Denholm17Victorian Tuberculosis Program, Melbourne, AustraliaGerard de Vries18KNCV Tuberculosis Foundation, Den Haag, The NetherlandsDennis Falzon1The Global TB Programme, World Health Organization, Geneva, SwitzerlandNathan Ford19Dept of HIV and Global Hepatitis Programme, World Health Organization, SwitzerlandMargaret Gale-Rowe20Public Health Agency of Canada, Ottawa, ON, CanadaChris Gilpin1The Global TB Programme, World Health Organization, Geneva, SwitzerlandEnrico Girardi21Istituto Nazionale Malattie Infettive L. Spallanzani, Rome, ItalyUn-Yeong Go22Dept of HIV/AIDS and TB Control Korea, Korea Centers for Disease Control and Prevention, Republic of KoreaDarshini Govindasamy23Health Systems Research Unit, South African Medical Research Council, South AfricaAlison D. Grant24Dept of Clinical Research, London School of Hygiene and Tropical Medicine, London, UKMalgorzata Grzemska1The Global TB Programme, World Health Organization, Geneva, SwitzerlandRoss Harris3Public Health England, London, UKC. Robert Horsburgh Jr25Dept of Epidemiology, Boston University School of Public Health, Boston, MA, USAAsker Ismayilov26Main Medical Department, Ministry of Justice, AzerbaijanErnesto Jaramillo1The Global TB Programme, World Health Organization, Geneva, SwitzerlandSandra Kik27McGill International TB Centre, and Dept of Epidemiology and Biostatistics, McGill University, Montreal, QC, CanadaKatharina Kranzer24Dept of Clinical Research, London School of Hygiene and Tropical Medicine, London, UKChristian Lienhardt1The Global TB Programme, World Health Organization, Geneva, SwitzerlandPhilip LoBue28Centers for Disease Control and Prevention, USAKnut Lönnroth1The Global TB Programme, World Health Organization, Geneva, Switzerland29Dept of Public Health Sciences, Karolinska Institute, Solna, SwedenGuy Marks30Woolcock Institute of Medical Research University of Sydney and UNSW Australia, Sydney, AustraliaDick Menzies27McGill International TB Centre, and Dept of Epidemiology and Biostatistics, McGill University, Montreal, QC, CanadaGiovanni Battista Migliori31WHO Collaborating Center for TB and Lung Diseases Fondazione S. Maugeri, Tradate, ItalyDavide Mosca32Migration Health Department, International Organization of Migration, Geneva, SwitzerlandYa Diul Mukadi33Infectious Disease Division, Bureau for Global Health, US Agency for International Development, Washington, DC, USAAlwyn Mwinga34Zambart Project, Lusaka, ZambiaLisa Nelson19Dept of HIV and Global Hepatitis Programme, World Health Organization, SwitzerlandNobuyuki Nishikiori35World Health Organization, Regional Office for the Western Pacific, PhilippinesAnouk Oordt-Speets36Pallas Health Research and Consultancy BV, Rotterdam, The NetherlandsMolebogeng Xheedha Rangaka2Dept of Infection and Population Health, University College London, London, UK37Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South AfricaAndreas Reis38Knowledge, Ethics and Research Department, World Health Organization, SwitzerlandLisa Rotz28Centers for Disease Control and Prevention, USAAndreas Sandgren39European Centre for Disease Prevention and Control, Stockholm, SwedenMonica Sañé Schepisi21Istituto Nazionale Malattie Infettive L. Spallanzani, Rome, ItalyHolger J. Schünemann40Dept of Clinical Epidemiology and Biostatistics and Dept of Medicine, GRADE Center, McMaster University, Hamilton, ON, CanadaSurender Kumar Sharma38Knowledge, Ethics and Research Department, World Health Organization, SwitzerlandGiovanni Sotgiu39European Centre for Disease Prevention and Control, Stockholm, SwedenHelen R. Stagg2Dept of Infection and Population Health, University College London, London, UKTimothy R. Sterling43Vanderbilt University School of Medicine, Nashville, TN, USATamara Tayeb44National TB Programme, Ministry of Health, Riyadh, Saudi ArabiaMukund Uplekar1The Global TB Programme, World Health Organization, Geneva, SwitzerlandMarieke J. van der Werf39European Centre for Disease Prevention and Control, Stockholm, SwedenWim Vandevelde45European AIDS Treatment Group, Brussels, BelgiumFemke van Kessel36Pallas Health Research and Consultancy BV, Rotterdam, The NetherlandsAnna van't Hoog46Academic Medical Centre, University of Amsterdam, Dept of Global Health, Amsterdam, The NetherlandsJay K. Varma28Centers for Disease Control and Prevention, USANatalia Vezhnina47HIV/TB and Penal System Projects, Russian FederationConstantia Voniatis48Clinical Laboratories, Ministry of Health, Nicosia, CyprusMarije Vonk Noordegraaf-Schouten36Pallas Health Research and Consultancy BV, Rotterdam, The NetherlandsDiana Weil1The Global TB Programme, World Health Organization, Geneva, SwitzerlandKarin Weyer1The Global TB Programme, World Health Organization, Geneva, SwitzerlandRobert John Wilkinson37Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa49Francis Crick Institute Mill Hill Laboratory, Dept of Medicine, Imperial College London, London, UKTakashi Yoshiyama50Fukujuji Hospital, Japan Anti Tuberculosis Association, Tokyo, JapanJean Pierre Zellweger51Tuberculosis Competence Centre, Berne, SwitzerlandMario Raviglione1The Global TB Programme, World Health Organization, Geneva, Switzerland
- High levels of neurological involvement but low mortality in miliary tuberculosis: a 6-year case-series from the UKBy Navin Venkatraman, Thomas King, David Bell, Gerrit Woltmann, Martin Wiselka, Ibrahim Abubakar and Manish PareekArticle | Published in 2016 in European Respiratory JournalNavin Venkatraman1Dept of Infection and HIV Medicine, University Hospitals of Leicester, Leicester, UKThomas King1Dept of Infection and HIV Medicine, University Hospitals of Leicester, Leicester, UKDavid Bell1Dept of Infection and HIV Medicine, University Hospitals of Leicester, Leicester, UKGerrit Woltmann2Dept of Respiratory Medicine, University Hospitals of Leicester, Leicester, UKMartin Wiselka1Dept of Infection and HIV Medicine, University Hospitals of Leicester, Leicester, UKIbrahim Abubakar3Research Dept of Infection and Population Health, University College London, London, UK4TB Section, Public Health England, London, UKManish Pareek1Dept of Infection and HIV Medicine, University Hospitals of Leicester, Leicester, UK4TB Section, Public Health England, London, UK5Dept of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK6Dept of Health Sciences, University of Leicester, Leicester, UK
- Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease: call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugeesBy Masoud Dara, Ivan Solovic, Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, Delia Goletti, Raquel Duarte, Stefano Aliberti, Fernando Maria de Benedictis, Graham Bothamley, Tom Schaberg, Ibrahim Abubakar, Brian Ward, Vitor Teixeira, Christina Gratziou and Giovanni Battista MiglioriArticle | Published in 2016 in European Respiratory JournalMasoud Dara1World Health Organization Office at the European Union, Brussels, BelgiumIvan Solovic2National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, Catholic University Ruzomberok, Ruzomberok, SlovakiaGiovanni Sotgiu3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyLia D'Ambrosio4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri IRCCS, Tradate, Italy5Public Health Consulting Group, Lugano, SwitzerlandRosella Centis4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri IRCCS, Tradate, ItalyDelia Goletti6National Institute for Infectious Diseases, Rome, ItalyRaquel Duarte7EPI Unit, Institute of Public Health, University of Porto, Porto, PortugalStefano Aliberti8School of Medicine and Surgery, University of Milan-Bicocca, UO Clinica Pneumologica, AO San Gerardo, Monza, ItalyFernando Maria de Benedictis9Paediatric Italian Society, Section Marche, Ancona, ItalyGraham Bothamley10Dept of Respiratory Medicine, Homerton University Hospital NHS Foundation Trust, London, UKTom Schaberg11Dept of Pneumology, Deaconess Hospital Rotenburg, Rotenburg (Wümme), GermanyIbrahim Abubakar12Centre for Infectious Disease Epidemiology, UCL and Tuberculosis Section, Public Health England, London, UKBrian Ward13European Respiratory Society, EU Affairs Dept, Brussels, BelgiumVitor Teixeira13European Respiratory Society, EU Affairs Dept, Brussels, BelgiumChristina Gratziou14University Respiratory Medicine Unit, Evgenidio Hospital, Athens, GreeceGiovanni Battista Migliori4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri IRCCS, Tradate, Italy
- Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung DiseaseBy Masoud Dara, Ivan Solovic, Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, Delia Goletti, Raquel Duarte, Stefano Aliberti, Fernando Maria de Benedictis, Graham Bothamley, Tom Schaberg, Ibrahim Abubakar, Brian Ward, Vitor Teixeira, Christina Gratziou and Giovanni Battista MiglioriMasoud Dara1World Health Organization Office at the European Union, Brussels, BelgiumIvan Solovic2National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, Catholic University Ruzomberok, Ruzomberok, SlovakiaGiovanni Sotgiu3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyLia D'Ambrosio4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri IRCCS, Tradate, Italy5Public Health Consulting Group, Lugano, SwitzerlandRosella Centis4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri IRCCS, Tradate, ItalyDelia Goletti6National Institute for Infectious Diseases, Rome, ItalyRaquel Duarte7EPI Unit, Institute of Public Health, University of Porto, Porto, PortugalStefano Aliberti8School of Medicine and Surgery, University of Milan-Bicocca, UO Clinica Pneumologica, AO San Gerardo, Monza, ItalyFernando Maria de Benedictis9Paediatric Italian Society, Section Marche, Ancona, ItalyGraham Bothamley10Dept of Respiratory Medicine, Homerton University Hospital NHS Foundation Trust, London, UKTom Schaberg11Dept of Pneumology, Deaconess Hospital Rotenburg, Rotenburg (Wümme), GermanyIbrahim Abubakar12Centre for Infectious Disease Epidemiology, UCL and Tuberculosis Section, Public Health England, London, UKBrian Ward13European Respiratory Society, EU Affairs Dept, Brussels, BelgiumVitor Teixeira13European Respiratory Society, EU Affairs Dept, Brussels, BelgiumChristina Gratziou14University Respiratory Medicine Unit, Evgenidio Hospital, Athens, GreeceGiovanni Battista Migliori4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri IRCCS, Tradate, Italy
- High levels of neurological involvement but low mortality in miliary tuberculosis: a 6-year case-series from the UKBy Navin Venkatraman, Thomas King, David Bell, Gerrit Woltmann, Martin Wiselka, Ibrahim Abubakar and Manish PareekNavin Venkatraman1Dept of Infection and HIV Medicine, University Hospitals of Leicester, Leicester, UKThomas King1Dept of Infection and HIV Medicine, University Hospitals of Leicester, Leicester, UKDavid Bell1Dept of Infection and HIV Medicine, University Hospitals of Leicester, Leicester, UKGerrit Woltmann2Dept of Respiratory Medicine, University Hospitals of Leicester, Leicester, UKMartin Wiselka1Dept of Infection and HIV Medicine, University Hospitals of Leicester, Leicester, UKIbrahim Abubakar3Research Dept of Infection and Population Health, University College London, London, UK4TB Section, Public Health England, London, UKManish Pareek1Dept of Infection and HIV Medicine, University Hospitals of Leicester, Leicester, UK4TB Section, Public Health England, London, UK5Dept of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK6Dept of Health Sciences, University of Leicester, Leicester, UK
- Advancing global programmatic management of latent tuberculosis infection for at risk populationsBy Haileyesus Getahun, Alberto Matteelli, Ibrahim Abubakar, Barbara Hauer, Emanuele Pontali and Giovanni Battista MiglioriHaileyesus Getahun1Global TB Programme, World Health Organisation, Geneva, SwitzerlandAlberto Matteelli2WHO Collaborating Centre for TB/HIV and TB Elimination, University of Brescia, Brescia, ItalyIbrahim Abubakar3MRC Clinical Trials Unit and Centre for Infectious Disease Epidemiology, UCL, London, UKBarbara Hauer4Respiratory Infections Unit, Dept for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, GermanyEmanuele Pontali5Dept of Infectious Diseases Galliera Hospital, Genoa, ItalyGiovanni Battista Migliori6WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, and a companion volume of self-assessment questions is available. In 2015, the first ERS Practical Handbook, on Noninvasive Ventilation, was added to the series
